14 November 2021: Clinical Research
Clinical Features and Temporal Lung Radiographic Changes in 25 Patients Recovering from COVID-19 Pneumonia: A Retrospective Case-Control Study
Chao Hu 1ABCDEG , Jian Ping Zeng 2ACDFG* , Ke Peng 3ABCDF* , Hong Xia 4BCEF , Huan Ming Zhang 5BCDEF , Zhi Zhong 5BCDE , Ming Yan Jiang 1ABDFG*DOI: 10.12659/MSM.933381
Med Sci Monit 2021; 27:e933381
Table 2 Comparison of laboratory findings between patients with moderate and severe COVID-19 pneumonia.
| Moderate (n=17) | Severe (n=9) | P | |
|---|---|---|---|
| White blood cell count, ×10/L | 4.54±1.99 | 5.41±2.36 | 0.411 |
| Neutrophil count, ×10/L | 2.47 (1.85–2.99) | 2.72 (2.66–3.04) | 0.136 |
| Lymphocyte count, ×10/L | 1.21±0.63 | 0.81±0.28 | 0.725 |
| Red blood cells, ×10/L | 127.06±22.94 | 127.11±17.14 | 0.359 |
| Platelet count, ×10/L | 181.67±83.07 | 228.89±56.70 | 0.394 |
| Alanine aminotransferase, U/L | 23.20±16.53 | 22.7±12.96 | 0.358 |
| Aspartate aminotransferase, U/L | 21.42±9.27 | 22.7±12.96 | 0.701 |
| Albumin, g/L | 41.90±4.52 | 39.45±7.83 | 0.132 |
| Globulin, g/L | 29.06±4.75 | 28.66±4.93 | 0.759 |
| Blood urea nitrogen | 3.18±1.34 | 4.88±1.72 | 0.548 |
| Creatinine, μmol/L | 61.11±16.19 | 81.33±22.91 | 0.471 |
| Lactate dehydrogenase, U/L | 180.5 (153–199.75) | 210 (180.5–304) | 0.04 |
| Creatine kinase, U/L | 66.44±29.78 | 118.44±119.94 | 0.002 |
| Potassium, mmol/L | 3.91±0.36 | 3.71±0.52 | 0.081 |
| Sodium, mmol/L | 140.8±2.09 | 134.7±6.52 | 0.048 |
| D-dimer, mg/L | 0.35±0.25 | 0.73±0.56 | 0.008 |
| Prothrombin times, s | 12.95±0.59 | 12.48±0.64 | 0.708 |
| Activated partial thromboplastin time, s | 39.43±2.95 | 40.13±4.59 | 0.12 |
| C-reactive protein | 6.35±6.62 | 25.49±26.52 | |
| Lactic acid | 2.67±0.61 | 2.61±1.36 | 0.057 |
| Procalcitonin | 17 (100%) | 6 (66.67%) | – |
| Serum ferritin | 405.83±199.30 | 817.4±707.03 | 0.112 |